Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Toxicol.

Sec. Environmental Toxicology

Imidacloprid Exposure in Rats Induces Cardiac Inflammatory Response through Activating TLR4/NF-κB/NLRP3 and JAK/STAT Signaling Pathways: Focus on the Berberine-Loaded Nanoliposomes

Provisionally accepted
Layla  AlkharashiLayla Alkharashi1Amina  FaragAmina Farag2Noha  Mohsen GamilNoha Mohsen Gamil3Yasmen  MahranYasmen Mahran4Amira  M. BadrAmira M. Badr1*Heba  BayoumiHeba Bayoumi2Mahmoud  MohamedMahmoud Mohamed5Awatif  BinmughramAwatif Binmughram6Aljawharah  AlquhayzAljawharah Alquhayz6Ghada  BinOaeidGhada BinOaeid6*Nervan  BayoumyNervan Bayoumy7Eman  ElwakeelEman Elwakeel2Reem  AtawiaReem Atawia4,8
  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457,, Riyadh, Saudi Arabia
  • 2Benha University Faculty of Medicine, Banha, Egypt
  • 3Misr University for Science and Technology, 6th of October City, Egypt
  • 4Ain Shams University Faculty of Pharmacy, Cairo, Egypt
  • 5Minia University Faculty of Pharmacy, Minya, Egypt
  • 6King Saud University, Riyadh, Saudi Arabia
  • 7King Saud University College of Medicine, Riyadh, Saudi Arabia
  • 8Southwestern Oklahoma State University College of Pharmacy, Weatherford, United States

The final, formatted version of the article will be published soon.

The neonicotinoid insecticide, imidacloprid (IMI), is one of the widely used pesticides with well-documented serious health effects that are noticeable with long-term exposure. However, the long-term effects of IMI on cardiac tissues have not been fully elucidated. Herein, we investigated the mechanisms of IMI-induced cardiotoxicity. Additionally, we examined the potential protective effects of the natural alkaloid, berberine (BBR), against IMI-induced cardiotoxicity. Rats received IMI (45mg/kg/day, orally) for thirty days, alone or in combination with BBR-loaded liposomes (BBR-Lip) at a dose of 10 mg/kg, intraperitoneally. Cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), oxidative stress, inflammatory markers, and histopathological alterations were assessed. IMI caused significant cardiac damage as shown by increased levels of cTnI and CK-MB and histopathological insults examined by H and E and transmission electron microscope. These changes were accompanied by the induction of oxidative stress and inflammatory markers. Additionally, IMI inhibited the expression of Nrf2, a powerful regulator of cellular antioxidant defense and activated inflammatory pathways by inducing expressions of TLR-4, NF-κB, NLRP3-inflammasome and gasdermin. Moreover, IMI induced cardiac expressions of TGF-β, p-JAK, and p-STAT, which worsens the oxidative stress and inflammatory status. Co-administration of BBR-Lip attenuated the biochemical, histological and molecular dysregulation induced by IMI in cardiac tissues. Collectively, this study provides mechanistic insights into the cardiotoxic effects of IMI as well as the potential protective effects of BBR-Lip.

Keywords: cardiotoxicity, imidacloprid, Inflammasomes, JAK/STAT, Berberine

Received: 08 Sep 2025; Accepted: 24 Nov 2025.

Copyright: © 2025 Alkharashi, Farag, Gamil, Mahran, M. Badr, Bayoumi, Mohamed, Binmughram, Alquhayz, BinOaeid, Bayoumy, Elwakeel and Atawia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Amira M. Badr
Ghada BinOaeid

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.